Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,002 | -31,699 | -22,772 | -14,940 | -6,950 |
| Depreciation Amortization | 322 | 1,654 | 1,367 | 811 | 315 |
| Accounts receivable | 898 | -851 | -1,075 | 74 | 102 |
| Accounts payable and accrued liabilities | 444 | -32 | 861 | 400 | 321 |
| Other Working Capital | -3,002 | -1,525 | -1,573 | -1,703 | -1,787 |
| Other Operating Activity | -696 | 2,693 | 1,422 | 148 | -96 |
| Operating Cash Flow | $-11,036 | $-29,760 | $-21,770 | $-15,210 | $-8,095 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,424 | -43,648 | -44,043 | -57,719 | -45,432 |
| PPE Investments | -150 | -804 | -244 | -188 | -100 |
| Investing Cash Flow | $16,274 | $-44,452 | $-44,287 | $-57,907 | $-45,532 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,089 | -8,182 | -6,120 | -4,039 | -2,002 |
| Common Stock Issued | 47,305 | 87,588 | 87,411 | 86,870 | 86,684 |
| Other Financing Activity | -34 | -1,436 | -1,436 | -1,436 | -1,042 |
| Financing Cash Flow | $45,182 | $77,970 | $79,855 | $81,395 | $83,640 |
| Beginning Cash Position | 13,396 | 9,638 | 9,638 | 9,638 | 9,638 |
| End Cash Position | 63,816 | 13,396 | 23,436 | 17,916 | 39,651 |
| Net Cash Flow | $50,420 | $3,758 | $13,798 | $8,278 | $30,013 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,036 | -29,760 | -21,770 | -15,210 | -8,095 |
| Capital Expenditure | -150 | -804 | -244 | -188 | -100 |
| Free Cash Flow | -11,186 | -30,564 | -22,014 | -15,398 | -8,195 |